Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants (Q43509136)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 October 2000

Language	Label	Description	Also known as
English	Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants	scientific article published on 31 October 2000

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants (English)

1 reference

Europe PubMed Central

24 November 2017

0 references

author name string

Gille H

1

1 reference

Europe PubMed Central

24 November 2017

Kowalski J

2

1 reference

Europe PubMed Central

24 November 2017

Li B

3

1 reference

Europe PubMed Central

24 November 2017

LeCouter J

4

1 reference

Europe PubMed Central

24 November 2017

Moffat B

5

1 reference

Europe PubMed Central

24 November 2017

Zioncheck TF

6

1 reference

Europe PubMed Central

24 November 2017

Pelletier N

7

1 reference

Europe PubMed Central

24 November 2017

Ferrara N

8

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

31 October 2000

1 reference

Europe PubMed Central

24 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

24 November 2017

276

1 reference

Europe PubMed Central

24 November 2017

5

1 reference

Europe PubMed Central

24 November 2017

3222-3230

1 reference

Europe PubMed Central

24 November 2017

Role of vascular endothelial growth factor in the regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

The biology of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Assay and purification of naturally occurring inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Signalling through the lipid products of phosphoinositide-3-OH kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M002016200

21 January 2018

Identifiers

10.1074/JBC.M002016200

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43509136&oldid=1990218993"